OSE Immunotherapeutics SA (OSE.PA)

EUR 7.17

(-1.38%)

Revenue Summary of OSE Immunotherapeutics SA

  • OSE Immunotherapeutics SA's latest annual revenue in 2023 was 2.22 Million EUR , down -87.83% from previous year.
  • OSE Immunotherapeutics SA's latest quarterly revenue in 2024 Q2 was 69.04 Million EUR , down 0.0% from previous quarter.
  • OSE Immunotherapeutics SA reported a annual revenue of 18.3 Million EUR in annual revenue 2022, down -30.43% from previous year.
  • OSE Immunotherapeutics SA reported a annual revenue of 26.3 Million EUR in annual revenue 2021, up 152.51% from previous year.
  • OSE Immunotherapeutics SA reported a quarterly revenue of 1.35 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • OSE Immunotherapeutics SA reported a quarterly revenue of 869 Thousand EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of OSE Immunotherapeutics SA (2023 - 2012)

Historical Annual Revenue of OSE Immunotherapeutics SA (2023 - 2012)

Year Revenue Revenue Growth
2023 2.22 Million EUR -87.83%
2022 18.3 Million EUR -30.43%
2021 26.3 Million EUR 152.51%
2020 10.41 Million EUR -59.86%
2019 25.95 Million EUR 6.12%
2018 24.45 Million EUR 266.0%
2017 6.68 Million EUR 1644.65%
2016 383 Thousand EUR 9475.0%
2015 4000.00 EUR 0.0%
2014 - EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%

Peer Revenue Comparison of OSE Immunotherapeutics SA

Name Revenue Revenue Difference
ABIONYX Pharma SA 4.64 Million EUR 52.004%
ABIVAX Société Anonyme 4.62 Million EUR 51.807%
Adocia SA 2.15 Million EUR -3.581%
Aelis Farma SA 9.05 Million EUR 75.403%
Biophytis S.A. - EUR -Infinity%
Advicenne S.A. 3.15 Million EUR 29.324%
genOway Société anonyme 20.04 Million EUR 88.891%
IntegraGen SA 12.53 Million EUR 82.237%
Medesis Pharma S.A. 300.03 Thousand EUR -642.249%
Neovacs S.A. 533.41 Thousand EUR -317.501%
NFL Biosciences SA - EUR -Infinity%
Plant Advanced Technologies SA 1.68 Million EUR -32.44%
Quantum Genomics Société Anonyme 19.79 Thousand EUR -11149.747%
Sensorion SA 4.74 Million EUR 53.047%
Theranexus Société Anonyme 296.33 Thousand EUR -651.524%
TME Pharma N.V. 17 Thousand EUR -13000.0%
Valbiotis SA 4.73 Million EUR 52.947%
TheraVet SA 1.07 Million EUR -106.576%
Valerio Therapeutics Société anonyme 1.8 Million EUR -23.722%
argenx SE 1.13 Billion EUR 99.804%
BioSenic S.A. 543 Thousand EUR -310.129%
Celyad Oncology SA 102 Thousand EUR -2083.333%
DBV Technologies S.A. - EUR -Infinity%
Galapagos NV 239.72 Million EUR 99.071%
Genfit S.A. 28.56 Million EUR 92.204%
GeNeuro SA - EUR -Infinity%
Hyloris Pharmaceuticals SA 2.08 Million EUR -6.708%
Innate Pharma S.A. 51.9 Million EUR 95.709%
Inventiva S.A. 17.47 Million EUR 87.258%
MaaT Pharma SA 2.22 Million EUR 0.045%
MedinCell S.A. 9.16 Million EUR 75.688%
Nanobiotix S.A. 30.05 Million EUR 92.591%
Onward Medical N.V. 532 Thousand EUR -318.609%
Oryzon Genomics S.A. 14.19 Million EUR 84.308%
Oxurion NV 263 Thousand EUR -746.768%
Pharming Group N.V. 245.31 Million EUR 99.092%
Poxel S.A. 1.98 Million EUR -12.418%
GenSight Biologics S.A. 1.26 Million EUR -75.77%
Transgene SA 1.18 Million EUR -88.091%
Financière de Tubize SA - EUR -Infinity%
UCB SA 5.25 Billion EUR 99.958%
Valneva SE 153.71 Million EUR 98.551%
Vivoryon Therapeutics N.V. -3.62 Million EUR 161.519%